Featured Research

from universities, journals, and other organizations

New Gene Holds Promise For Controlling Crohn's And Other Inflammatory Diseases

Date:
May 26, 1999
Source:
Boston University
Summary:
A new gene involved in common inflammatory diseases, like rheumatoid arthritis and Crohn's disease, was recently discovered by scientists at Boston University's School of Dental Medicine.

Researchers At Boston University Goldman School Of Dental Medicine Discover New Gene

(Boston, MA) - A new gene involved in common inflammatory diseases, like rheumatoid arthritis and Crohn's disease, was recently discovered by scientists at Boston University's School of Dental Medicine.

The scientists identified the gene that controls production of Tumor Necrosis Factor alpha (or TNF), a molecule the body produces when it needs to destroy unwanted tissues -when it is fighting infection, for example. The researchers believe that this molecule is also implicated in a wide variety of inflammatory diseases - diseases in which the body literally attacks itself - including periodontal disease, septic shock, rheumatoid arthritis, lupus, Crohn's disease, and diabetes.

"We believe this discovery offers new insights into how the body regulates the fundamental pathway involved in inflammation and opens up new ways to find and to treat currently untreatable diseases, " explains Dr. Salomon Amar, Associate Professor of Oral Biology and Periodontology at Boston University's School of Dental Medicine. Amar led a team of four researchers at the Boston University School of Dental Medicine and School of Medicine.

The scientists deleted portions of the promoter of the TNF gene and tested whether or not the gene continued to function. They found that if a particular sequence were removed, cells could not produce TNF. Further, they found that this sequence bound a previously unknown transcription factor - a molecule that regulates other molecules like TNF that exert a powerful effect on the body. They named this molecule LITAF (lipopolysaccharide-induced transcription factor).

Anti-TNF therapies for Crohn's disease are under development by pharmaceutical companies, however the protein molecules under development are too expensive and too difficult to administer to be ideal for the long-term therapy necessary for chronic conditions like Crohn's disease. The Boston University discovery will utilize LITAF to produce small molecule therapeutics which can be more easily and economically used to treat chronic inflammatory conditions like Crohn's disease.

The research leading to this discovery was supported by the National Institute of Craniofacial and Dental Research of the National Institutes of Health. It was reported in the Proceedings of the National Academy of Sciences (Vol. 96).


Story Source:

The above story is based on materials provided by Boston University. Note: Materials may be edited for content and length.


Cite This Page:

Boston University. "New Gene Holds Promise For Controlling Crohn's And Other Inflammatory Diseases." ScienceDaily. ScienceDaily, 26 May 1999. <www.sciencedaily.com/releases/1999/05/990526060636.htm>.
Boston University. (1999, May 26). New Gene Holds Promise For Controlling Crohn's And Other Inflammatory Diseases. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/1999/05/990526060636.htm
Boston University. "New Gene Holds Promise For Controlling Crohn's And Other Inflammatory Diseases." ScienceDaily. www.sciencedaily.com/releases/1999/05/990526060636.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins